Assessment of Anti-Helicobacter Pylori Eradication Regimens in Basrah Gastroenterology and Hepatology Hospital

Kim J, Wang TC. Helicobacter pylori and Gastric Cancer. Gastrointest Endosc Clin N Am. 2021;31(3):451-465. doi: 10.1016/j.giec.2021.03.003. DOI: https://doi.org/10.1016/j.giec.2021.03.003

Sjomina O, Pavlova J, Niv Y, Leja M. Epidemiology of Helicobacter pylori infection. Helicobacter. 2018;23(1):e12514. doi: 10.1111/hel.12514. DOI: https://doi.org/10.1111/hel.12514

Elshair M, Ugai T, Oze I, Kasugai Y, Koyanagi Y, Hara K, et al. Impact of socioeconomic status and sibling number on the prevalence of Helicobacter pylori infection: a cross-sectional study in a Japanese population. Nagoya J Med Sci. 2022;84(2):374-387. doi: 10.18999/nagjms.84.2.374.

Rowland M, Kumar D, Daly L. O′ Connor P, Vaughan D, Drumm B. Low rates of Helicobacter pylori reinfection in children. Gastroenterology. 1999;117:336-341. doi: 10.1053/gast.1999.0029900336. DOI: https://doi.org/10.1053/gast.1999.0029900336

Tindberg Y, Blennow M, Granström M. Clinical symptoms and social factors in a cohort of children spontaneously clearing Helicobacter pylori infection. Acta Paediatrica. 1999;88(6):631-635. doi: 10.1080/08035259950169288. DOI: https://doi.org/10.1111/j.1651-2227.1999.tb00012.x

Solnick JV, Schauer DB. Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases. Clin Microbiol Rev. 2001;14(1):59-97. doi: 10.1128/CMR.14.1.59-97.2001. DOI: https://doi.org/10.1128/CMR.14.1.59-97.2001

Lee Y-C, Lin J-T. Screening and treating Helicobacter pylori infection for gastric cancer prevention on the population level. J Gastroenterol Hepatol. 2017;32(6):1160-1169. doi: 10.1111/jgh.13726. DOI: https://doi.org/10.1111/jgh.13726

Malfertheiner P, Megraud F, Rokkas T, Gisbert JP, Liou J-M, Schulz C, et al. Management of Helicobacter pylori infection: The Maastricht VI/Florence consensus report. Gut. 2022;71(9):1724-1762. doi: 10.1136/gutjnl-2022-327745. DOI: https://doi.org/10.1136/gutjnl-2022-327745

Gold BD, Gilger MA, Czinn SJ. New diagnostic strategies for detection of Helicobacter pylori infection in pediatric patients. Gastroenterol Hepatol. 2014;10(12 Suppl 7):1-19.

Abbas M, Sharif FA, Osman SM, Osman AM, El Sanousi SM, Magzoub M, et al. Prevalence and associated symptoms of Helicobacter pylori infection among schoolchildren in Kassala State, East of Sudan. Interdiscip Perspect Infect Dis. 2018;2018:4325752. doi: 10.1155/2018/4325752. DOI: https://doi.org/10.1155/2018/4325752

Gisbert JP, Pajares JM. 13C-urea breath test in the diagnosis of Helicobacter pylori infection -- a critical review. Aliment Pharmacol Ther. 2004;20(10):1001-1017. doi: 10.1111/j.1365-2036.2004.02203.x. DOI: https://doi.org/10.1111/j.1365-2036.2004.02203.x

Patel SK, Pratap CB, Jain AK, Gulati AK, Nath G. Diagnosis of Helicobacter pylori: what should be the gold standard? World J Gastroenterol. 2014;20(36):12847-12859. doi: 10.3748/wjg.v20.i36.12847. DOI: https://doi.org/10.3748/wjg.v20.i36.12847

Patel SK, Mishra GN, Pratap CB, Jain AK, Nath G. Helicobacter pylori is not eradicated after triple therapy: a nested PCR based study. Biomed Res Int. 2014;2014:483136. doi: 10.1155/2014/483136. DOI: https://doi.org/10.1155/2014/483136

Nyssen OP, Perez-Aisa A, Tepes B, Castro-Fernandez M, Kupcinskas J, Jonaitis L, et al. Adverse event profile during the treatment of Helicobacter pylori: A real-world experience of 22,000 patients from the european registry on H. pylori management (Hp-EuReg). Am J Gastroenterol. 2021;116(6):1220-1229. doi: 10.14309/ajg.0000000000001246. DOI: https://doi.org/10.14309/ajg.0000000000001246

Hafeez M, Qureshi ZA, Khattak AL, Saeed F, Asghar A, Azam K, et al. Helicobacter pylori eradication therapy: Still a challenge. Cureus. 2021;13(5):e14872. doi: 10.7759/cureus.14872. DOI: https://doi.org/10.7759/cureus.14872

Miehlke S, Meining A, Lehn N, Höchter W, Weingart J, Simon T, et al. Comparison of omeprazole, metronidazole and clarithromycin with omeprazole/amoxicillin dual-therapy for the cure of Helicobacter pylori infection. Digestion. 1998;59(6):646-650. doi: 10.1159/000007569. DOI: https://doi.org/10.1159/000007569

Zuckerman JM. Macrolides and ketolides: azithromycin, clarithromycin, telithromycin. Infect Dis Clin North Am. 2004;18(3):621-649. doi: 10.1016/j.idc.2004.04.010. DOI: https://doi.org/10.1016/j.idc.2004.04.010

Graham DY, Lee YC, Wu MS. Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence. Clin Gastroenterol Hepatol. 2014;12(2):177-186. doi: 10.1016/j.cgh.2013.05.028. DOI: https://doi.org/10.1016/j.cgh.2013.05.028

Boyanova L, Hadzhiyski P, Kandilarov N, Markovska R, Mitov I. Multidrug resistance in Helicobacter pylori: current state and future directions. Expert Rev Clin Pharmacol. 2019;12(9):909-915. doi: 10.1080/17512433.2019.1654858. DOI: https://doi.org/10.1080/17512433.2019.1654858

Hu Y, Zhu Y, Lu NH. Novel and effective therapeutic regimens for Helicobacter pylori in an era of increasing antibiotic resistance. Front Cell Infect Microbiol. 2017;7:168. doi: 10.3389/fcimb.2017.00168. DOI: https://doi.org/10.3389/fcimb.2017.00168

Azab ET, Thabit AK, McKee S, Al-Qiraiqiri A. Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens? Gut Pathog. 2022;14(1):24. doi: 10.1186/s13099-022-00502-3. DOI: https://doi.org/10.1186/s13099-022-00502-3

Liou JM, Chen CC, Chen MJ, Chen CC, Chang CY, Fang YJ, et al. Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicenter, open-label, randomized trial. Lancet. 2013;381(9862):205-213. doi: 10.1016/S0140-6736(12)61579-7. DOI: https://doi.org/10.1016/S0140-6736(12)61579-7

Qian J, Ye F, Zhang J, Yang YM, Tu HM, Jiang Q, et al. Levofloxacin-containing triple and sequential therapy or standard sequential therapy as the first line treatment for Helicobacter pylori eradication in China. Helicobacter. 2012;17(6):478-485. doi: 10.1111/j.1523-5378.2012.00993.x. DOI: https://doi.org/10.1111/j.1523-5378.2012.00993.x